Article
Hypertrophic and dilated cardiomyopathy mutations differentially affect the molecular force generation of mouse alpha-cardiac myosin in the laser trap assay.
American journal of physiology. Heart and circulatory physiology - 1 Jul 2007
Debold Edward P, Schmitt J P, Patlak J B, Beck S E, Moore J R, Seidman J G, Seidman C, Warshaw D M
Abstract excerpt
Point mutations in cardiac myosin, the heart's molecular motor, produce distinct clinical phenotypes: hypertrophic (HCM) and dilated (DCM) cardiomyopathy. Do mutations alter myosin's molecular mechanics in a manner that is predictive of the clinical outcome? We have directly characterized the maximal force-generating capacity (F(max)) of two HCM (R403Q, R453C) and two DCM (S532P, F764L) mutant myosins isolated...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
